In basal-like breast cancer, a 2020 study identified associations between key receptors such as Tumor necrosis factor receptors (TNFRs), Transforming growth factor-beta receptor type 1 (TGFBR1), and EGFR, and ELK1 [69]. This evidence concerns the gene ELK1 and breast cancer.